Figure 1.
Kaplan-Meier survival curves depicting overall survival, hepatic progression-free survival and progression-free survival for patients with metastatic neuroendocrine tumor treated with radioembolization.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.